AR Asset Management’s Pfizer PFE Stock Holding History

AR Asset Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.46M	Hold	158,661	–	–	0.86%	36
2025 Q4	$3.95M	Sell	158,661 -304	-0.2%	-$7.67K	0.81%	36
2025 Q3	$4.05M	Hold	158,965	–	–	0.85%	35
2025 Q2	$3.85M	Buy	158,965 +1,000	+0.6%	+$23.3K	0.86%	37
2025 Q1	$4M	Buy	157,965 +23,000	+17%	+$602K	0.91%	36
2024 Q4	$3.58M	Sell	134,965 -20,000	-13%	-$542K	0.81%	39
2024 Q3	$4.49M	Hold	154,965	–	–	1%	34
2024 Q2	$4.34M	Hold	154,965	–	–	1.05%	32
2024 Q1	$4.3M	Buy	154,965 +14,300	+10%	+$397K	1.05%	33
2023 Q4	$4.05M	Sell	140,665 -1,000	-0.7%	-$30.2K	1.06%	31
2023 Q3	$4.7M	Buy	141,665 +90	+0.1%	+$3.18K	1.32%	23
2023 Q2	$5.19M	Hold	141,575	–	–	1.39%	22
2023 Q1	$5.78M	Hold	141,575	–	–	1.55%	19
2022 Q4	$7.25M	Hold	141,575	–	–	2.06%	13
2022 Q3	$6.2M	Hold	141,575	–	–	1.85%	14
2022 Q2	$7.42M	Hold	141,575	–	–	2.1%	10
2022 Q1	$7.33M	Hold	141,575	–	–	1.85%	13
2021 Q4	$8.36M	Hold	141,575	–	–	2.12%	11
2021 Q3	$6.09M	Hold	141,575	–	–	1.71%	18
2021 Q2	$5.54M	Hold	141,575	–	–	1.55%	20
2021 Q1	$5.13M	Hold	141,575	–	–	1.53%	20
2020 Q4	$5.21M	Sell	141,575 -7,645	-5%	-$280K	1.68%	16
2020 Q3	$5.2M	Sell	149,220 -401	-0.3%	-$14.1K	1.83%	17
2020 Q2	$4.64M	Sell	149,621 -1,054	-0.7%	-$35.8K	1.76%	17
2020 Q1	$4.67M	Buy	150,675 +21,080	+16%	+$718K	1.92%	17
2019 Q4	$4.82M	Hold	129,595	–	–	1.61%	18
2019 Q3	$4.42M	Sell	129,595 -1,598	-1%	-$58.1K	1.56%	19
2019 Q2	$5.39M	Hold	131,193	–	–	1.95%	15
2019 Q1	$5.29M	Hold	131,193	–	–	1.98%	13
2018 Q4	$5.43M	Hold	131,193	–	–	2.33%	13
2018 Q3	$5.49M	Hold	131,193	–	–	2.02%	14
2018 Q2	$4.52M	Hold	131,193	–	–	1.75%	17
2018 Q1	$4.42M	Sell	131,193 -799	-0.6%	-$27.5K	1.78%	17
2017 Q4	$4.54M	Hold	131,992	–	–	1.75%	18
2017 Q3	$4.47M	Sell	131,992 -320	-0.2%	-$10.3K	1.77%	17
2017 Q2	$4.22M	Hold	132,312	–	–	1.71%	17
2017 Q1	$4.29M	Sell	132,312 -1,599	-1%	-$50.4K	1.78%	17
2016 Q4	$4.13M	Hold	133,911	–	–	1.76%	17
2016 Q3	$4.3M	Hold	133,911	–	–	1.86%	16
2016 Q2	$4.47M	Hold	133,911	–	–	1.88%	16
2016 Q1	$3.77M	Hold	133,911	–	–	1.64%	20
2015 Q4	$4.1M	Sell	133,911 -799	-0.6%	-$25.1K	1.87%	17
2015 Q3	$4.01M	Hold	134,710	–	–	1.78%	18
2015 Q2	$4.29M	Hold	134,710	–	–	1.75%	19
2015 Q1	$4.45M	Sell	134,710 -799	-0.6%	-$25.4K	1.78%	18
2014 Q4	$4M	Hold	135,509	–	–	1.61%	21
2014 Q3	$3.8M	Sell	135,509 -80	-0.1%	-$2.25K	1.54%	23
2014 Q2	$3.82M	Hold	135,589	–	–	1.53%	22
2014 Q1	$4.13M	Hold	135,589	–	–	1.73%	18
2013 Q4	$3.94M	Hold	135,589	–	–	1.67%	20
2013 Q3	$3.69M	Hold	135,589	–	–	1.64%	19
2013 Q2	$3.6M	Buy	+135,589	New	+$3.75M	1.61%	20

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

AR Asset Management's PFE Position: Q1 2026 in Review

AR Asset Management held its Pfizer (PFE) position steady in Q1 2026 at 158,661 shares worth $4.46M. The position accounts for 0.86% of the portfolio, ranked #36.

AR Asset Management first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $8.36M in Q4 2021. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

AR Asset Management held 158,661 shares of Pfizer worth $4.46M as of Q1 2026.
AR Asset Management left its Pfizer share count unchanged in Q1 2026.
Pfizer made up 0.86% of AR Asset Management's portfolio in Q1 2026, its #36 holding.
AR Asset Management first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
AR Asset Management's Pfizer position peaked at $8.36M in Q4 2021.
2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on AR Asset Management's 13F filing for Q1 2026, filed 13 May 2026.